XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Class A common stock
Common stock
Class B common stock
Common stock
Additional paid-in capital
Retained Earnings
Shareholders' and other affiliates' net investment
Net Due To and Due From Shareholders and Other Affiliates
Total
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY              
Balance as of December 31, 2021 as originally reported         $ 83,586,722 $ (17,028,310) $ 66,558,412
Retroactive application of recapitalization $ 37 $ 3,697   $ 66,554,678 $ (83,586,722) $ 17,028,310  
Retroactive application of recapitalization (in shares) 373,473 36,973,877          
Adjusted balance as of December 31, 2021 $ 37 $ 3,697   66,554,678     66,558,412
Beginning balance (in shares) at Dec. 31, 2021 373,473 36,973,877          
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY              
Distributions and net transfer to shareholders and other affiliates       (20,766,162)     (20,766,162)
Stock-based compensation expense     $ 1,268,222       1,268,222
Net Income (Loss)       17,017,928     17,017,928
Ending balance at Mar. 31, 2022 $ 37 $ 3,697 1,268,222 62,806,444     64,078,400
Ending balance (in shares) at Mar. 31, 2022 373,473 36,973,877          
Beginning balance (in shares) at Dec. 31, 2021 373,473 36,973,877          
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY              
Net Income (Loss)             42,919,934
Ending balance at Jun. 30, 2022 $ 37 $ 3,697 1,321,510 64,293,271     65,618,515
Ending balance (in shares) at Jun. 30, 2022 373,473 36,973,877          
Beginning balance at Mar. 31, 2022 $ 37 $ 3,697 1,268,222 62,806,444     64,078,400
Beginning balance (in shares) at Mar. 31, 2022 373,473 36,973,877          
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY              
Distributions and net transfer to shareholders and other affiliates       (24,415,179)     (24,415,179)
Stock-based compensation expense     53,288       53,288
Net Income (Loss)       25,902,006     25,902,006
Ending balance at Jun. 30, 2022 $ 37 $ 3,697 1,321,510 64,293,271     65,618,515
Ending balance (in shares) at Jun. 30, 2022 373,473 36,973,877          
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY              
Adjusted balance as of December 31, 2021 [1]             59,004,036
Beginning balance at Dec. 31, 2022 $ 37 $ 3,697 1,422,630 57,577,672     59,004,036
Beginning balance (in shares) at Dec. 31, 2022 373,473 36,973,877          
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY              
Distributions and net transfer to shareholders and other affiliates       (4,193,093)     (4,193,093)
Stock-based compensation expense     51,079       51,079
Forfeiture of private placement warrants     890,001       890,001
Issuance of common stock upon the reverse recapitalization, net of transaction costs $ 849   17,869,735       17,870,584
Issuance of common stock upon the reverse recapitalization, net of transaction costs (in shares) 8,492,537            
Issuance of common stock related to PIPE Investment $ 133   9,501,782       9,501,915
Issuance of common stock related to PIPE Investment (in shares) 1,333,963            
Issuance of common stock related to lock-up agreement $ 42   4,194       4,236
Issuance of common stock related to lock-up agreement (in shares) 421,100            
Recognition of derivative liability related to earnout     (242,211,404)       (242,211,404)
Recognition of derivative liability related equity incentive plan     (1,189,685)       (1,189,685)
Earnout stock-based compensation expense for UHG employee options     4,448,077       4,448,077
Transaction costs related to equity issuance     (2,932,426)       (2,932,426)
Net Income (Loss)       (204,504,328)     (204,504,328)
Reclassification of negative APIC     212,146,017 (212,146,017)      
Ending balance at Mar. 31, 2023 $ 1,061 $ 3,697   (363,265,766)     (363,261,008)
Ending balance (in shares) at Mar. 31, 2023 10,621,073 36,973,877          
Beginning balance at Dec. 31, 2022 $ 37 $ 3,697 1,422,630 57,577,672     $ 59,004,036
Beginning balance (in shares) at Dec. 31, 2022 373,473 36,973,877          
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY              
Exercise of stock options under the 2023 Plan (in shares)             1,494
Net Income (Loss)             $ 40,858,431
Ending balance at Jun. 30, 2023 $ 1,137 $ 3,697 764,887 (117,903,007)     (117,133,286)
Ending balance (in shares) at Jun. 30, 2023 11,381,736 36,973,877          
Beginning balance at Mar. 31, 2023 $ 1,061 $ 3,697   (363,265,766)     (363,261,008)
Beginning balance (in shares) at Mar. 31, 2023 10,621,073 36,973,877          
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY              
Stock-based compensation expense     410,530       410,530
Exercise of stock options under the 2023 Plan $ 1   132,411       132,412
Exercise of stock options under the 2023 Plan (in shares) 12,643            
Forfeiture of stock options under the 2023 Plan     479,742       479,742
Exercise of stock warrants $ 75   (75)        
Exercise of stock warrants (in shares) 748,020            
Transaction costs related to equity issuance     (257,721)       (257,721)
Net Income (Loss)       245,362,759     245,362,759
Ending balance at Jun. 30, 2023 $ 1,137 $ 3,697 $ 764,887 $ (117,903,007)     (117,133,286)
Ending balance (in shares) at Jun. 30, 2023 11,381,736 36,973,877          
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY              
Adjusted balance as of December 31, 2021 [1]             $ (117,133,286)
[1] Retroactively restated as of December 31, 2022 for the Reverse Recapitalization as a result of the Business Combination as described in Notes 1 and 2.